Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Biogen Inc shares valued at $300,105 were sold by Izzar Rachid on Jul 08 ’25. At $135.00 per share, Izzar Rachid sold 2,223 shares. The insider’s holdings dropped to 6,330 shares worth approximately $0.84 million following the completion of this transaction.
Also, Izzar Rachid purchased 2,223 shares, netting a total of over 300,105 in proceeds.
Before that, Singhal Priya had sold 3,806 shares from its account. In a trade valued at $480,508, the Head of Development traded Biogen Inc shares for $126.25 each. Upon closing the transaction, the insider’s holdings decreased to 3,806 shares, worth approximately $0.72 million.
Analysts at HSBC Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in late April. As of April 04, 2025, Argus has decreased its “Buy” rating to a “Hold” for BIIB. Earlier on February 11, 2025, Bernstein initiated its rating. Their recommendation was “a Mkt perform” for BIIB stock.
Analyzing BIIB Stock Performance
On last trading session,, Biogen Inc [NASDAQ: BIIB] rose 1.23% to $132.59. The stock’s lowest price that day was $130.04, but it reached a high of $132.65 in the same session. During the last five days, there has been a surge of approximately 3.03%. Over the course of the year, Biogen Inc shares have dropped approximately -41.49%. Shares of the company reached a 52-week high of $157.09 on 03/10/25 and a 52-week low of $110.04 on 04/09/25.
Support And Resistance Levels for Biogen Inc (BIIB)
According to the 24-hour chart, there is a support level at 130.84, which, if violated, would cause prices to drop to 129.10. In the upper region, resistance lies at 133.49. The next price resistance is at 134.40. RSI (Relative Strength Index) is 55.38 on the 14-day chart, showing neutral technical sentiment.
Is Biogen Inc subject to short interest?
Stocks of Biogen Inc saw a sharp rise in short interest on 2025-06-30 jumping by 0.21 million shares to 4.0 million. Data from Yahoo Finance shows that the short interest on 2025-05-30 was 3.8 million shares. A jump of 5.13% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.79 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.79.
Which companies own the most shares of Biogen Inc (BIIB)?
In terms of Biogen Inc share price expectations, FactSet research, analysts set an average price target of 196 in the next 12 months, up nearly 49.64% from the previous closing price of $130.98. Analysts anticipate Biogen Inc stock to reach 270 by 2025, with the lowest price target being 118. In spite of this, 32 analysts ranked Biogen Inc stock as Buy at the end of 2025. On January 02, 2025, Piper Sandler assigned a price target of “a Neutral” to the stock and downgraded coverage with a $138.
